Filter
431
Filtered Results: 431
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
113
Language
Document type
No document type
283
Guidelines
54
Studies & Reports
53
Manuals
23
Strategic & Response Plan
9
Situation Updates
3
Fact sheets
3
Training Material
2
Infographics
1
Countries / Regions
India
20
Kenya
15
Uganda
14
Liberia
13
South Africa
13
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Western and Central Europe
9
Sierra Leone
8
Malawi
8
Global
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Asia
6
Cambodia
5
Namibia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
Congo, Democratic Republic of
3
Ghana
3
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Latin America and the Carribbean
3
Guinea
2
Senegal
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Africa
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
174
Clinical Guidelines
40
Pharmacy & Technologies
18
Public Health
13
Women & Child Health
13
Key Resources
10
Capacity Building
6
Toolboxes
HIV
55
Mental Health
37
TB
33
Pharmacy
29
COVID-19
24
AMR
16
Ebola
11
Rapid Response
10
NTDs
10
Caregiver
6
Conflict
4
Refugee
4
Planetary Health
4
Health Financing Toolbox
4
Natural Hazards
3
Global Health Education
3
NCDs
3
Specific Hazards
2
Disability
1
Cholera
1
Zika
1
Social Ethics
1
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
First Revised Edition
March 2000
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan ...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse...
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as ... policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package.
Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en
October 2018
HIV testing services
Strategic communication is used to raise awareness of issues among specific target populations. It aims to provide timely, evidence-based, authoritative information and guidance needed for public health action. Proper implementation of strategic communication leads t...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: ...-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdda.europa.eu/publications/edr/trends-developments/2018
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
World Drug Report 2018
-5-
Strategic Overview
